Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company ...

Putting on weight during the first trimester of pregnancy can cause the foetus to have excess fat distribution in the upper ...

Following an intermittent fasting regimen is more effective than adopting a traditional diet, latest research has revealed. A ...

Park Avenue Securities LLC boosted its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 34.5% in the 4th ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

TNDM's shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario ...

DexCom Inc. DXCM is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary results for the fourth quarter and fiscal 2024 on Jan. 13, 2025. The company’s ...

Tandem Diabetes Care, Inc.’s TNDM impressive strategic initiatives are expected to bolster growth in the upcoming quarters. A robust diabetes market provides a favorable opportunity for the company’s ...

and a new study into genetically altered beta cell therapy tested in type 1 diabetes. We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insuli ...